Cannabis Withdrawal Is Real, Driven by CB1 Receptor Changes, and May Be Worse for Women | Research

The takeaway

Cannabis withdrawal involves downregulation of CB1 receptors that reverses with extended abstinence, and emerging evidence suggests women may experience faster onset and greater severity of certain withdrawal symptoms.

Readers experiencing or anticipating cannabis withdrawal symptoms.

CB1 receptor density recovers with extended abstinence, explaining why withdrawal is time-limited

What the researchers found

The review synthesized preclinical and clinical research on cannabis withdrawal, identifying several key findings.

Long-term cannabis use downregulates CB1 receptors throughout the brain. This reduced receptor density directly correlates with withdrawal severity during early abstinence. Importantly, CB1 receptor density recovers with extended abstinence, providing a neurobiological basis for why withdrawal symptoms are time-limited.

Sex differences are emerging as an important factor. Females showed increased rate and severity of a subset of cannabis withdrawal symptoms compared to males. This parallels sex differences seen in withdrawal from other substances and may have implications for treatment approaches.

The review also noted that most clinical withdrawal studies have predominantly male samples, creating a significant knowledge gap about the female experience of cannabis withdrawal.

Why it matters

Cannabis withdrawal syndrome was only added to the DSM-5 in 2013, and awareness remains limited among both clinicians and the public. Understanding the neurobiological basis (CB1 downregulation) and the influence of sex on withdrawal severity can improve clinical support for people trying to quit cannabis.

The numbers in context

CB1 receptor density decreases with chronic cannabis use. Reduced CB1 density correlates with increased withdrawal severity. CB1 receptor density recovers with extended abstinence. Females show increased rate and severity of some withdrawal symptoms.

How the study worked

Narrative review of preclinical (animal) and clinical (human) research on the neurobiology of cannabis withdrawal, with specific attention to CB1 receptor dynamics, endocannabinoid system components, and sex differences.

What this study cannot tell us

Many clinical studies are limited by small sample sizes and predominantly male participants. The review acknowledges that endocannabinoid enzymes, negative allosteric modulators, and other neurobiological systems that may influence withdrawal have been insufficiently studied. Preclinical findings may not directly translate to human withdrawal experiences.

How to read the evidence

Moderate evidence from a narrative review synthesizing preclinical and clinical research on established neurobiological mechanisms.

When this study was published

Published in 2017. Cannabis withdrawal research has continued to expand.

The bigger picture

Cannabis withdrawal has been minimized for decades ("cannabis isn't addictive"), but the neurobiological evidence reviewed here shows a clear mechanism: chronic use downregulates the receptors, and when cannabis is removed, the depleted receptor population cannot maintain normal endocannabinoid signaling, producing withdrawal symptoms until receptors recover. The sex difference findings add another dimension to the growing recognition that addiction affects men and women differently.

Questions still open

How long does full CB1 receptor recovery take after different durations and intensities of cannabis use? Why do women appear to experience more severe withdrawal for some symptoms? Could pharmacological support during the CB1 recovery period reduce withdrawal severity?

Common questions

Is cannabis withdrawal real?

Yes. This review details the neurobiological mechanism: chronic cannabis use causes downregulation of CB1 receptors, and when cannabis is removed, the reduced receptor population cannot maintain normal function, causing withdrawal symptoms. The symptoms (irritability, anxiety, sleep disturbance, decreased appetite) are time-limited because CB1 receptors recover with abstinence.

Do women have worse cannabis withdrawal than men?

Emerging evidence suggests yes, at least for certain symptoms. Women showed increased rate and severity of a subset of withdrawal symptoms compared to men. However, most withdrawal studies have predominantly male samples, so the full picture of sex differences is not yet clear.

Read the original research

Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.

Current addiction reports, 4(2), 75-81

View on PubMed ↗Publisher’s paper ↗

Citation

Schlienz, Nicolas J; Budney, Alan J; Lee, Dustin C; Vandrey, Ryan. (2017). Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.. Current addiction reports, 4(2), 75-81. https://doi.org/10.1007/s40429-017-0143-1